17th St. Gallen International Breast Cancer Conference - PDF Version  

17-20 March 2021, Vienna, Austria & Online  

The 17th St.Gallen International Breast Cancer Conference will be held in Vienna, Austria, from 17 - 20 March 2021 and virtually. For many years this traditional world-renowned conference attracts close to 3,000 delegates from all over the globe, and has set the benchmark in primary therapy of early breast cancer. The conference is acclaimed for its high level quality as well as its eminent speakers representing the best in breast cancer research and therapy worldwide. The highlight of the congress is the St. Gallen Breast Cancer Consensus conference on Saturday, in which up to 60 experts engage in a discussion and live-voting process on therapy of early breast cancer, which shapes treatment procedures for the coming two years. Participants are sure to witness history in the making for the good of breast cancer patients worldwide. 

In 2021, the conference offers two options to join: in person in Vienna and also virtually. Make sure not to miss this year’s top scientific programme and the famous, educative St.Gallen Consensus Panel Session!  

The Swiss-based Foundation St. Gallen Oncology Conferences (SONK) is the official organiser. The organising and scientific committees involve experts from St. Gallen, Vienna, Italy and the USA.  

The conference, taking place in Vienna, Austria, for the fourth time, combines the best of Swiss precision and thoroughness with the strengths of Vienna as a destination: a centrally located meeting place of cultures, which attracts researchers and clinicians from all over the world.  

The event is supported by an industry exhibition, showcasing the latest technology for breast cancer diagnosis and care. Industry will also have the opportunity to hold their own activities for the benefit of attendees, both onsite and on the virtual conference platform, offering ample new opportunities to get in touch. 

Attendees have the opportunity to submit abstracts for the conference until mid-December 2020, the best of which will receive special awards. All accepted abstracts will be displayed as posters in a designated poster exhibition. 

The conference is pending to be accredited with around 18 continuing medical education (CME) credits. 

Take advantage of our early-bird rates. More information can be found at https://www.oncoconferences.ch/events/bcc-2021/